6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
17m ago	Nik Rupp Joins Funko as Senior Vice President of Brand and Marketing
17m ago	Invesco Reports Results for the Three Months Ended March 31, 2026
17m ago	Coca-Cola Reports First Quarter 2026 Results and Updates Full Year Guidance
17m ago	Precore Gold Welcomes Tenured Geologist Raúl Carbajal as Senior Project Manager at Its Arikepay Project in Peru
17m ago	Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets

About

Viridian Therapeutics Inc (NASDAQ:VRDN) — investor relations, events, news, and company updates on 6ix.

Latest News

Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑1 Clinical Trial in Active Thyroid Eye Disease

Bambusa Therapeutics Appoints Todd James Chief Financial Officer

Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics Prepares for Transformational 2026

Financials

Revenue

$70.85 M

Market Cap

$1.93 B

EPS

-3.32

Community Chat

Ask AI